Insights

Market leadership Artivion is a leading provider in cardiac and vascular surgical solutions with a broad portfolio including cryopreserved allografts, prosthetic valves, stents, and stent-grafts, presenting multiple cross-sell opportunities across surgical specialties and hospital procurement.

Austin expansion Significant investment in Austin, Texas, including a 160,000 square foot manufacturing campus acquired for around $20.3 million, signaling capacity expansion and potential increases in local supply capability and service reach for U.S. customers.

Global footprint Manufacturing in Atlanta, Austin, and Hechingen with sales offices across Europe, Asia, and South America creates opportunities for regional channel partnerships, faster regional support, and expanded distribution agreements.

Financial health Revenue range of 250 to 500 million with a recent funding round of 100 million suggests strong growth momentum and potential for strategic collaborations, co‑development deals, and larger contract opportunities with health systems.

Industry partnerships Recent collaborations and events with MedTech conferences and packaging circularity initiatives indicate openness to ecosystem partnerships, value-based procurements, and opportunities to pilot innovative packaging, sustainability, and supply-chain efficiency solutions.

CryoLife, Inc. Tech Stack

CryoLife, Inc. uses 8 technology products and services including Ultimate Software, Atlassian, Power BI, and more. Explore CryoLife, Inc.'s tech stack below.

  • Ultimate Software
    Applicant Tracking Systems
  • Atlassian
    Application Development & Management
  • Power BI
    Business Intelligence
  • Wellpass
    Corporate Learning Management Systems
  • Oracle
    Enterprise
  • Microsoft Word
    Office Suites
  • Office 365
    Office Suites
  • WP Engine
    Platform As A Service

Media & News

CryoLife, Inc.'s Email Address Formats

CryoLife, Inc. uses at least 2 format(s):
CryoLife, Inc. Email FormatsExamplePercentage
Last.First@cryolife.comDoe.John@cryolife.com
89%
First.Last@cryolife.comJohn.Doe@cryolife.com
8%
LastFirst@cryolife.comDoeJohn@cryolife.com
2%
First-Last@cryolife.comJohn-Doe@cryolife.com
1%
First.Last@artivion.comJohn.Doe@artivion.com
96%
First.Middle@artivion.comJohn.Michael@artivion.com
3%
LastF@artivion.comDoeJ@artivion.com
1%

Frequently Asked Questions

What is CryoLife, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact CryoLife, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CryoLife, Inc.'s stock symbol?

Minus sign iconPlus sign icon
CryoLife, Inc. is a publicly traded company; the company's stock symbol is AORT.

What is CryoLife, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
CryoLife, Inc.'s official website is artivion.com and has social profiles on LinkedIn.

How much revenue does CryoLife, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, CryoLife, Inc.'s annual revenue is estimated to be $10M - $25M.

What is CryoLife, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
CryoLife, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CryoLife, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, CryoLife, Inc. has approximately 1K employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: C. D.Chief Executive Officer: J. S.Chief Executive Officer: R. A.. Explore CryoLife, Inc.'s employee directory with LeadIQ.

What industry does CryoLife, Inc. belong to?

Minus sign iconPlus sign icon
CryoLife, Inc. operates in the Biotechnology industry.

What technology does CryoLife, Inc. use?

Minus sign iconPlus sign icon
CryoLife, Inc.'s tech stack includes Ultimate SoftwareAtlassianPower BIWellpassOracleMicrosoft WordOffice 365WP Engine.

What is CryoLife, Inc.'s email format?

Minus sign iconPlus sign icon
CryoLife, Inc.'s email format typically follows the pattern of Last.First@cryolife.com. Find more CryoLife, Inc. email formats with LeadIQ.

How much funding has CryoLife, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, CryoLife, Inc. has raised $451M in funding. The last funding round occurred on Jan 18, 2024 for $100M.

When was CryoLife, Inc. founded?

Minus sign iconPlus sign icon
CryoLife, Inc. was founded in 1984.
CryoLife, Inc. logo

CryoLife, Inc.

BiotechnologyGeorgia, United States1001-5000 Employees

CryoLife, Inc., operating under the Artivion brand, is a biotechnology company focused on the manufacture, processing, and distribution of medical devices and implantable tissues for cardiac and vascular surgery, with a specialization in aortic repair, including cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. The company aims to provide simple, high-quality solutions to help cardiac and vascular surgeons address diseases of the aorta and improve patient outcomes, drawing on decades of expertise and recent acquisitions and partnerships. The company serves cardiac and vascular surgeons and operates across a global network, with manufacturing facilities in Atlanta, Georgia; Austin, Texas; and Hechingen, Germany, and a presence in sales and distribution across Europe, Asia, and the Americas. It is based in Kennesaw, Georgia, and maintains a sizable global workforce. In 2026, Artivion expanded its Austin operations by taking full ownership of its longtime manufacturing base there.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AORT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1984
Employees
1001-5000

Section iconFunding & Financials

  • $451M

    CryoLife, Inc. has raised a total of $451M of funding over 3 rounds. Their latest funding round was raised on Jan 18, 2024 in the amount of $100Mas a post_ipo_debt.

  • $10M - $25M

    CryoLife, Inc.'s revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $451M

    CryoLife, Inc. has raised a total of $451M of funding over 3 rounds. Their latest funding round was raised on Jan 18, 2024 in the amount of $100Mas a post_ipo_debt.

  • $10M - $25M

    CryoLife, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.